The European Medicines Agency on Monday 25 October approved the administration of booster doses of the Moderna laboratory's anti-Covid vaccine to people aged 18 and over, as health authorities worried about a drop in the level of protection after the first injections.
To discover
Covid-19: the third vaccine dose, instructions for use
Read also Marie-Paule Kieny: "In this booster strategy, the vaccines in the study phase will have their place"
Spikevax is the second booster to receive the green light after Pfizer / BioNTech's vaccine earlier this month.
“
Data showed that a third dose of Spikevax given six to eight months after the second dose resulted in increased antibody levels in adults with declining antibody levels
,” said the European Medicines Agency. .
